Question 1

Am I eligible for this trial based on my medical history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the FTD/TPI treatment compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of FTD/TPI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection clinical trial (NCT04457297). Contact the study team or your healthcare provider for specific answers.

What this study is about